NAA Survey for U.S. Fish Farmers on Unmet Medication and Vaccine Needs
The National Aquaculture Association (NAA), as a member of the Aquatic Drug Approval Coalition, would like to survey and assess the current and future unmet medication and vaccine needs for U.S. fish farmers.
Although several new medications have been added to the aquaculture “medicine chest” over the past 10 years, the number of U.S. Food and Drug Administration (FDA) approved fish medications is still very limited. As certain priority medications have been approved for specific claims, collaborative research efforts have shifted to reflect new priorities - including generating data to support new approvals, identifying emerging disease issues for which treatment options are currently limited or non-existent, and seeking approval for non-therapeutics such as those used for skeletal marking, spawning, sex reversal, and fish sedation/anesthesia.
Results from this survey will be used to 1) establish medication and vaccine priorities and direction of effort; 2) engage with current sponsors or find new medication or vaccine sponsors as needed; and 3) generate data to support new approvals or new (expanded) claims for medications that are currently approved. Survey answers will be strictly confidential, and no personal, farm, or organization information will be divulged. A survey summary will be announced when the information is compiled.
Click here to download the Introduction to the Survey (pdf)
Click here to download the Survey (pdf)